MERCURO, GIUSEPPE
 Distribuzione geografica
Continente #
EU - Europa 361.896
NA - Nord America 23.488
AS - Asia 9.543
SA - Sud America 1.501
AF - Africa 1.175
OC - Oceania 78
Continente sconosciuto - Info sul continente non disponibili 10
Totale 397.691
Nazione #
IT - Italia 356.514
US - Stati Uniti d'America 23.123
SG - Singapore 3.529
CN - Cina 3.118
UA - Ucraina 1.465
BR - Brasile 1.180
SE - Svezia 1.174
VN - Vietnam 843
ZA - Sudafrica 825
GB - Regno Unito 605
FI - Finlandia 604
DE - Germania 547
FR - Francia 464
IN - India 422
HK - Hong Kong 299
BD - Bangladesh 255
CA - Canada 205
KR - Corea 164
AR - Argentina 108
IQ - Iraq 90
TR - Turchia 89
KE - Kenya 81
PK - Pakistan 79
ID - Indonesia 78
PH - Filippine 72
BE - Belgio 69
NL - Olanda 69
MX - Messico 68
RU - Federazione Russa 66
ES - Italia 65
JP - Giappone 61
SA - Arabia Saudita 59
CO - Colombia 56
PL - Polonia 49
UZ - Uzbekistan 46
MY - Malesia 44
ZM - Zambia 44
AU - Australia 43
EC - Ecuador 40
AT - Austria 39
AE - Emirati Arabi Uniti 38
MA - Marocco 36
NP - Nepal 32
CL - Cile 29
IR - Iran 27
UG - Uganda 27
VE - Venezuela 24
JO - Giordania 22
PY - Paraguay 20
TH - Thailandia 20
TN - Tunisia 20
EG - Egitto 19
IE - Irlanda 19
IL - Israele 19
PE - Perù 19
NG - Nigeria 18
JM - Giamaica 17
TW - Taiwan 17
RO - Romania 16
GH - Ghana 15
GR - Grecia 15
KW - Kuwait 15
LK - Sri Lanka 15
LT - Lituania 15
NZ - Nuova Zelanda 14
PT - Portogallo 13
AZ - Azerbaigian 12
FJ - Figi 12
KH - Cambogia 12
KZ - Kazakistan 12
OM - Oman 12
BO - Bolivia 11
DZ - Algeria 11
TZ - Tanzania 11
BG - Bulgaria 10
CR - Costa Rica 10
MW - Malawi 10
UY - Uruguay 10
ZW - Zimbabwe 10
NO - Norvegia 9
CU - Cuba 8
ET - Etiopia 8
SN - Senegal 8
TT - Trinidad e Tobago 8
AL - Albania 7
DO - Repubblica Dominicana 7
EU - Europa 7
HR - Croazia 7
KG - Kirghizistan 7
MU - Mauritius 7
CH - Svizzera 6
HN - Honduras 6
LC - Santa Lucia 6
MT - Malta 6
PA - Panama 6
PR - Porto Rico 6
QA - Qatar 6
RS - Serbia 6
SV - El Salvador 6
BW - Botswana 5
Totale 397.577
Città #
Cagliari 345.467
Uta 9.994
Fairfield 2.497
Ashburn 1.866
Woodbridge 1.746
Singapore 1.627
Houston 1.379
Chandler 1.286
Ann Arbor 1.137
San Jose 1.126
Dallas 1.095
Wilmington 1.025
Seattle 957
Boardman 948
Cambridge 892
Nyköping 793
Jacksonville 774
Beijing 599
Dearborn 456
Helsinki 366
Los Angeles 366
Nanjing 293
Santa Clara 278
Hong Kong 270
Lauterbourg 269
The Dalles 267
Boston 252
Ho Chi Minh City 247
Hefei 227
Johannesburg 217
Council Bluffs 202
New York 200
Shanghai 174
Buffalo 170
Hanoi 167
San Diego 154
Seoul 147
São Paulo 108
Guangzhou 105
Dong Ket 104
Shenyang 102
Milan 98
Nanchang 90
Redwood City 89
Toronto 82
Hebei 80
London 80
Atlanta 76
Cape Town 76
Tianjin 74
Chicago 73
Changsha 72
Pretoria 71
Jiaxing 70
Orem 64
Munich 60
Redondo Beach 55
Frankfurt am Main 52
Brooklyn 51
Norwalk 48
Chennai 46
Mountain View 45
Da Nang 44
Jinan 44
Nairobi 44
Tokyo 44
Brussels 43
Phoenix 43
Lusaka 42
Tashkent 42
Nuremberg 40
Amsterdam 38
Orange 38
Verona 38
Dhaka 37
Rio de Janeiro 37
Durban 35
Mumbai 34
Belo Horizonte 33
Washington 33
Auburn Hills 31
Baghdad 31
Columbus 31
Montreal 31
Pune 31
Wuhan 31
Warsaw 29
Zhengzhou 29
Haiphong 28
Denver 27
San Francisco 27
Rome 26
Sassari 25
Ningbo 24
Stockholm 24
Jakarta 23
Kuala Lumpur 23
Kunming 23
Ankara 22
Falls Church 22
Totale 383.048
Nome #
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.375
Metabolomic approach to profile functional and metabolic changes in heart failure 4.235
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.182
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.942
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.881
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.584
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.564
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.539
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.478
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.434
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.405
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.351
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 3.158
Epicardial fat thickness, an emerging cardiometabolic risk factor, is increased in young adults born preterm 3.146
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.126
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 3.114
Metaboreflex-mediated hemodynamic abnormalities in individuals with coronary artery disease without overt signs or symptoms of heart failure 3.081
A case of SAPHO syndrome with endodontic implications and treatment with biologic drugs 3.064
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 3.056
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 3.023
Metabolomics and heart failure: a new and promising scientific approach 2.996
Coronary Artery Disease 2.939
Nitrergic system and plasmatic methylarginines: Evidence of their role in the perinatal programming of cardiovascular diseases 2.928
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.844
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.829
Pharmacological treatment of vagal hyperactivity, a rare but potentially fatal cause of sudden cardiac death 2.797
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.767
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 2.767
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.762
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.752
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 2.752
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.716
Fully-textile polymer-based ECG electrodes: overcoming the limits of metal-based textiles 2.706
Metabolomics, a promising approach to translational research in cardiology 2.695
Zumba Fitness and Women’s Cardiovascular Health: A SYSTEMATIC REVIEW 2.568
Aquatic exercise improves motor impairments in people with Parkinson's disease, with similar or greater benefits than land-based exercise: a systematic review 2.552
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.549
Premature vascular deterioration in young patients affected by Wilson's disease: a pilot study 2.548
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.493
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.432
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.418
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.415
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 2.368
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.326
The perioperative dental screening and management of patients undergoing cardiothoracic, vascular surgery and other cardiovascular invasive procedures: A systematic review 2.312
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.309
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.294
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.283
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.250
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.242
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.213
Impaired central arterial elasticity in young adults born with intrauterine growth restriction 2.212
null 2.211
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.195
null 2.190
Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology. 2.188
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.177
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.175
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.163
Reply to comment on: “Nordic Walking for the Management of People with Parkinson Disease: A Systematic Review” 2.133
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.118
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 2.111
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.106
Antineoplastic drug-induced cardiotoxicity: A redox perspective 2.102
Supervised aquatic-based exercise for men with coronary artery disease: a meta-analysis of randomised controlled trials 2.094
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 2.085
Abnormal atrial activation at surface electrocardiogram examination in born underweight young adults 2.084
Antihypertensive therapy in children: differences in medical approach between the United States and Europe 2.082
The need of a gender-corrected evidence based medicine 2.081
Clinical metabolomics and hematic ADMA predict the future onset of cardiorenal syndrome in young grown-up subjects who were born preterm 2.050
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 2.023
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 2.000
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.989
Apical periodontitis and cardiovascular diseases: previous findings and ongoing research 1.974
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.973
Altered aortic upper wall TDI velocity is inversely related with left ventricular diastolic function in operated tetralogy of Fallot 1.967
An old drug for use in the prevention of sudden infant unexpected death due to vagal hypertonia 1.953
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.941
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.934
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.932
Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioning 1.927
Current views on anthracycline cardiotoxicity 1.911
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.882
Arterial hypertension in the female world: Pathophysiology and therapy 1.878
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.872
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.834
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.793
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.789
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.767
Gender differences in cardiology: is it time for new guidelines? 1.767
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.733
A systematic overview to quantify the gender imbalance in cardiovascular rehabilitation trials 1.720
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.716
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.702
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.683
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.671
Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 1.661
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.642
Impaired Forearm Blood Flow and Vasodilator Reserve in Healthy Postmenopausal Women 1.621
Atrial fibrillation in a preterm newborn with structurally normal heart 1.597
Totale 244.969
Categoria #
all - tutte 521.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 521.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.226 0 0 0 0 0 0 0 0 0 0 0 3.226
2021/202218.526 2.175 1.204 956 1.607 1.395 1.332 989 1.155 1.895 1.689 1.954 2.175
2022/202326.476 2.651 3.900 3.513 2.267 2.246 2.258 1.128 2.121 1.730 1.465 2.036 1.161
2023/202430.921 1.668 1.166 1.376 2.261 3.046 4.843 4.853 2.585 1.702 2.132 2.768 2.521
2024/202555.265 10.433 13.562 9.788 6.654 3.121 4.922 3.911 375 708 521 587 683
2025/202617.504 956 784 2.130 1.444 1.292 1.424 2.973 1.643 1.300 1.799 930 829
Totale 398.721